NCT07430046API RE2T
Repurposing Mirtazapine in Rett Syndrome
This phase II study evaluates the safety and efficacy of mirtazapine in females with Rett syndrome, including effects on mood, sleep and motor symptoms.
Listed as recruitingINTERVENTIONAL
Record summary
This phase II study evaluates the safety and efficacy of mirtazapine in females with Rett syndrome, including effects on mood, sleep and motor symptoms.
What this record cannot establish
Registry data requiring human review; it cannot determine eligibility or individual benefit.
Study level
Documented countryIT
Centre level4 Sites named in the sources
Original sourceClinicalTrials.gov
Human reviewHuman-reviewed
Centre level
Centre level · 4 Sites named in the sources · IT
Unità di Neuropsichiatria Infantile, IRCCS, Istituto Giannina Gaslini, Genova · Genova · ITListed as recruiting
UOC di Neuropsichiatria Infantile, Policlinico Universitario "Gaetano Martino" di Messina, University of Messina. Messina · Messina · ITListed as recruiting
Centro Epilessia - Unità Neurologia Pediatrica, ASST Ospedale Santi Carlo Paolo - Dipartimento Scienze della Salute, Università di Milano · Milan · ITListed as recruiting
Unità di Pediatria, Dipartimento della Donna e dei Bambini - Policlinico S. M. alle Scotte. Siena · Siena · ITListed as recruiting
Source and review
Résumé ou traduction assisté par IA : peut contenir des erreurs et ne remplace ni une relecture humaine ni un avis médical.
Source updated · Feb 24, 2026
Source updated · Feb 23, 2026
Synced · Sep 19, 2026
Published · Sep 19, 2026
Human review · Sep 19, 2026